We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$16.7B
AUM Growth
+$2.72B
Cap. Flow
+$2.51B
Cap. Flow %
15.03%
Top 10 Hldgs %
35.19%
Holding
1,938
New
561
Increased
410
Reduced
355
Closed
390

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$309M
2
NXPI icon
NXP Semiconductors
NXPI
+$122M
3
NVDA icon
NVIDIA
NVDA
+$97.7M
4
AMGN icon
Amgen
AMGN
+$79M
5
SHEL icon
Shell
SHEL
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 8.51%
2 Technology 8.13%
3 Consumer Discretionary 5.54%
4 Financials 4.12%
5 Communication Services 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETON icon
1351
Eton Pharmaceutcials
ETON
$1.32B
$133K ﹤0.01%
+10,000
New +$101K
KRMD icon
1352
KORU Medical Systems
KRMD
$187M
$132K ﹤0.01%
+34,300
New +$111K
EB
1353
DELISTED
Eventbrite
EB
$132K ﹤0.01%
+39,200
New +$130K
OMER icon
1354
PUT
Omeros
OMER
$845M
$129K ﹤0.01%
+13,100
New +$89.9K
KOPN icon
1355
Kopin
KOPN
$586M
$129K ﹤0.01%
+94,700
New +$90.9K
VOXX
1356
DELISTED
VOXX International Corporation Class A
VOXX
$128K ﹤0.01%
17,400
RCKT icon
1357
Rocket Pharmaceuticals
RCKT
$343M
$126K ﹤0.01%
10,000
-4,500
-31% -$67.7K
EBS icon
1358
Emergent Biosolutions
EBS
$379M
$124K ﹤0.01%
13,000
CDMO
1359
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$124K ﹤0.01%
10,000
DCGO icon
1360
DocGo
DCGO
$64.2M
$123K ﹤0.01%
+29,100
New +$112K
BW icon
1361
Babcock & Wilcox
BW
$1.18B
$123K ﹤0.01%
75,000
-25,000
-25% -$52.9K
ZM icon
1362
Zoom
ZM
$27.1B
$122K ﹤0.01%
+1,500
New +$118K
ENFN
1363
DELISTED
Enfusion, Inc.
ENFN
$121K ﹤0.01%
+11,700
New +$113K
RAIL icon
1364
FreightCar America
RAIL
$263M
$120K ﹤0.01%
13,400
RGTI icon
1365
PUT
Rigetti Computing
RGTI
$4.39B
$114K ﹤0.01%
+7,500
New +$28K
GDXJ icon
1366
VanEck Junior Gold Miners ETF
GDXJ
$6.86B
$107K ﹤0.01%
2,500
-5,200
-68% -$252K
NMRA icon
1367
Neumora Therapeutics
NMRA
$306M
$106K ﹤0.01%
+10,000
New +$120K
CBIO
1368
Crescent Biopharma
CBIO
$546M
$106K ﹤0.01%
+4,238
New +$116K
MYO icon
1369
Myomo
MYO
$35.9M
$101K ﹤0.01%
+15,700
New +$76.4K
ACRS icon
1370
Aclaris Therapeutics
ACRS
$715M
$101K ﹤0.01%
40,700
+29,200
+254% +$72.7K
ABEO icon
1371
Abeona Therapeutics
ABEO
$355M
$100K ﹤0.01%
18,000
ABEV icon
1372
Ambev
ABEV
$47.9B
$98.6K ﹤0.01%
+53,292
New +$118K
ELUT icon
1373
Elutia
ELUT
$38.9M
$95.7K ﹤0.01%
25,600
RPT
1374
Rithm Property Trust
RPT
$94.4M
$94.4K ﹤0.01%
5,300
RIG icon
1375
PUT
Transocean
RIG
$5.48B
$93.8K ﹤0.01%
25,000

Similar funds

Jefferies Financial Group's Q4 2024 Portfolio in Review

As of Q4 2024, Jefferies Financial Group held 1,938 positions worth $16.7B, up 19% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Jefferies Financial Group deployed $2.51B of net new capital in Q4 2024, opening 561 new positions and adding to 410 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,500,000 shares worth $49.3M.

By sector, the portfolio is most concentrated in Healthcare at 8.5% of assets, down from 9.8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $309M trimmed.

  • Jefferies Financial Group's largest Q4 2024 buy was Agios Pharmaceuticals: 1,500,000 shares worth $49.3M.
  • Jefferies Financial Group added most to Amazon in Q4 2024, an estimated $349M increase.
  • Jefferies Financial Group's biggest Q4 2024 reduction was Apple, cutting an estimated $309M.
  • Jefferies Financial Group fully exited Kellanova in Q4 2024, selling an estimated $23.2M.
  • Jefferies Financial Group's ten largest holdings make up 35% of its $16.7B portfolio in Q4 2024.
  • Jefferies Financial Group opened 561 new positions and closed 390 in Q4 2024.
  • Jefferies Financial Group's portfolio value rose 19% quarter-over-quarter to $16.7B.

Based on Jefferies Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.